More importantly, cancer cell lines with lower expression levels of CDKN1A showed greater sensitivity to M1 virus than those with higher levels, and the deficiency of CDKN1A is a ubiquitous event in colorectal cancer patients. This evidence concerns the gene CDKN1A and colorectal cancer.